Loading clinical trials...
Loading clinical trials...
A Randomized, Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Varisolve Polidocanol Endovenous Microfoam (PEM) 0.5% and 1% Compared to Vehicle for the Treatment on Saphenofemoral Junction (SFJ) Incompetence "VANISH-2"
Conditions
Interventions
polidocanol injectable foam, 0.125%
polidocanol injectable foam, 0.5%
+2 more
Locations
12
United States
Dothan, Alabama, United States
San Diego, California, United States
San Diego, California, United States
Lafayette, Indiana, United States
Frederick, Maryland, United States
Hunt Valley, Maryland, United States
Start Date
November 1, 2010
Primary Completion Date
September 1, 2011
Completion Date
August 1, 2014
Last Updated
April 21, 2021
NCT07449728
NCT05735639
NCT06711120
NCT06693245
NCT03416413
NCT04487314
Lead Sponsor
Boston Scientific Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions